To the Editor

Affiliations

¹ Vincent Obstetrics & Gynecology Massachusetts General Hospital Harvard Medical School Boston, MA.
² Public Health Sciences Fred Hutchinson Cancer Research Center Seattle, WA Department of Obstetrics & Gynecology University of Washington Seattle, WA.
³ Department of Medicine Division of Epidemiology and Community Health University of Minnesota Minneapolis, MN Department of Medicine Minneapolis VA Health Care System Minneapolis, MN.
⁴ Department of Medicine Division of Epidemiology & Community Health University of Minnesota Minneapolis, MN Center for Care Delivery & Outcomes Research Minneapolis VA Health Care System Minneapolis, MN.
⁵ Department of Family Medicine and Public Health University of California at San Diego La Jolla, CA.
⁶ Kaiser Permanente Washington Health Research Institute Seattle, WA.
⁷ Public Health Sciences Fred Hutchinson Cancer Research Center Seattle, WA.

Comment

Caroline M Mitchell et al. Menopause. 2020 Jul.

. 2020 Jul;27(7):836-837.

doi: 10.1097/GME.0000000000001606.

¹ Vincent Obstetrics & Gynecology Massachusetts General Hospital Harvard Medical School Boston, MA.
² Public Health Sciences Fred Hutchinson Cancer Research Center Seattle, WA Department of Obstetrics & Gynecology University of Washington Seattle, WA.
³ Department of Medicine Division of Epidemiology and Community Health University of Minnesota Minneapolis, MN Department of Medicine Minneapolis VA Health Care System Minneapolis, MN.
⁴ Department of Medicine Division of Epidemiology & Community Health University of Minnesota Minneapolis, MN Center for Care Delivery & Outcomes Research Minneapolis VA Health Care System Minneapolis, MN.
⁵ Department of Family Medicine and Public Health University of California at San Diego La Jolla, CA.
⁶ Kaiser Permanente Washington Health Research Institute Seattle, WA.
⁷ Public Health Sciences Fred Hutchinson Cancer Research Center Seattle, WA.

No abstract available

Comment in

In Reply.
Lukas VA, Simon JA. Lukas VA, et al. Menopause. 2020 Jul;27(7):837-840. doi: 10.1097/GME.0000000000001607. Menopause. 2020. PMID: 32604326 No abstract available.

MsFLASH network vaginal health trial: absence of evidence is NOT evidence of absence.
Lukas VA, Simon JA. Lukas VA, et al. Menopause. 2020 Jun;27(6):722-725. doi: 10.1097/GME.0000000000001516. Menopause. 2020. PMID: 32068684

1. Lukas VA, Simon JA. MsFLASH network vaginal health trial: absence of evidence is NOT evidence of absence. Menopause 2020; 27:722–725.
1. Constantine GD, Simon JA, Pickar JH, et al. The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy. Menopause 2017; 24:409–416.
1. Davila GW, Singh A, Karapanagiotou I, et al. Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 2003; 188:382–388.
1. Greendale GA, Zibecchi L, Petersen L, Ouslander JG, Kahn B, Ganz PA. Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 1999; 2:197–204.
1. Mitchell CM, Reed SD, Diem S, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Intern Med 2018; 178:681–690.